Prescribed process

Honeywell has revised its Experian Process Knowledge System to aid the batch-production processes used in pharmaceuticals

The pharmaceutical industry represents a different set of challenges for process control than the bulk chemicals and plastics sectors. Instead of gargantuan plants where large reactors make tonnes upon tonnes of relatively low-value products on a continuous basis, a pharmaceutical plant is smaller, with products produced in batches. But while each batch may only be a couple of hundred or even tens of kilos, the complex chemicals produced, active ingredients for drugs, are likely to be extremely valuable.

For the process-control engineer, this is a tricky prospect. In a continuous reactor, the conditions — temperature, pressure, concentration and so on — must be kept constant, so the task of the control system is to keep everything within certain set-points. But in a batch reaction, the system never reaches this steady state: everything continually changes. Moreover, a pharmaceutical plant has to be flexible; day to day, a single reactor may produce a range of different products.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox